ARS Pharmaceuticals updates corporate presentation; no material new data disclosed

ARS Pharmaceuticals, Inc.

Company released an updated slide deck for investor meetings on December 6, 2022.
Presentation highlights needle-free epinephrine solution for Type I allergic reactions.
No new clinical, regulatory, or financial milestones were announced in the filing.

item 7.01 item 9.01

ARS Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-299482

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.